Carin M. A. Rademaker

3.7k total citations
68 papers, 2.5k citations indexed

About

Carin M. A. Rademaker is a scholar working on Pediatrics, Perinatology and Child Health, Psychiatry and Mental health and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Carin M. A. Rademaker has authored 68 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Pediatrics, Perinatology and Child Health, 13 papers in Psychiatry and Mental health and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Carin M. A. Rademaker's work include Neonatal and fetal brain pathology (21 papers), Pharmaceutical studies and practices (14 papers) and Neonatal Respiratory Health Research (10 papers). Carin M. A. Rademaker is often cited by papers focused on Neonatal and fetal brain pathology (21 papers), Pharmaceutical studies and practices (14 papers) and Neonatal Respiratory Health Research (10 papers). Carin M. A. Rademaker collaborates with scholars based in Netherlands, United Kingdom and United States. Carin M. A. Rademaker's co-authors include Toine C. G. Egberts, Alfred F.A.M. Schobben, Imke H. Bartelink, Floris Groenendaal, John N. van den Anker, Marcel P. H. van den Broek, Aukje K. Mantel‐Teeuwisse, Liset van Dijk, Diana A. van Riet‐Nales and Verica Ivanovska and has published in prestigious journals such as PLoS ONE, PEDIATRICS and International Journal of Pharmaceutics.

In The Last Decade

Carin M. A. Rademaker

68 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Carin M. A. Rademaker Netherlands	28	1.3k	398	332	301	271	68	2.5k
Matitiahu Berkovitch Israel	30	928 0.7×	284 0.7×	389 1.2×	499 1.7×	609 2.2×	184	3.3k
Noel Cranswick Australia	28	890 0.7×	176 0.4×	312 0.9×	252 0.8×	152 0.6×	89	2.3k
Eran Kozer Israel	28	751 0.6×	239 0.6×	128 0.4×	193 0.6×	523 1.9×	110	2.9k
Ralph E. Kauffman United States	30	2.0k 1.5×	476 1.2×	938 2.8×	421 1.4×	550 2.0×	121	4.4k
Sarah W. Alander United States	6	1.1k 0.8×	130 0.3×	455 1.4×	161 0.5×	176 0.6×	9	1.9k
Haleh Bagheri France	31	373 0.3×	169 0.4×	479 1.4×	296 1.0×	160 0.6×	176	3.0k
Ilan Matok Israel	32	478 0.4×	322 0.8×	134 0.4×	139 0.5×	657 2.4×	101	2.5k
Isaac Teitelbaum United States	31	317 0.2×	568 1.4×	296 0.9×	118 0.4×	138 0.5×	107	4.1k
Susan M. Abdel‐Rahman United States	32	1.6k 1.2×	331 0.8×	818 2.5×	264 0.9×	446 1.6×	158	4.4k
Bernard Bégaud France	30	525 0.4×	131 0.3×	726 2.2×	209 0.7×	240 0.9×	79	3.0k

Countries citing papers authored by Carin M. A. Rademaker

Since Specialization

Citations

This map shows the geographic impact of Carin M. A. Rademaker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carin M. A. Rademaker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carin M. A. Rademaker more than expected).

Fields of papers citing papers by Carin M. A. Rademaker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carin M. A. Rademaker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carin M. A. Rademaker. The network helps show where Carin M. A. Rademaker may publish in the future.

Co-authorship network of co-authors of Carin M. A. Rademaker

This figure shows the co-authorship network connecting the top 25 collaborators of Carin M. A. Rademaker. A scholar is included among the top collaborators of Carin M. A. Rademaker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carin M. A. Rademaker. Carin M. A. Rademaker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rademaker, Carin M. A., et al.. (2023). The efficacy of the entire-vial dosing of emicizumab: Real-world evidence on plasma concentrations, bleeds, and drug waste. Research and Practice in Thrombosis and Haemostasis. 7(2). 100074–100074. 10 indexed citations

Rademaker, Carin M. A., et al.. (2021). Pharmacokinetics and Associated Efficacy of Emicizumab in Humans: A Systematic Review. Clinical Pharmacokinetics. 60(11). 1395–1406. 23 indexed citations

Maarseveen, Erik M. van, et al.. (2020). Comparison between coagulation factor VIII quantified with one‐stage activity assay and with mass spectrometry in haemophilia A patients: Proof of principle. International Journal of Laboratory Hematology. 42(6). 819–826. 1 indexed citations

Groenendaal, Floris, Marcel P. H. van den Broek, Carin M. A. Rademaker, et al.. (2019). Pharmacokinetics of morphine in encephalopathic neonates treated with therapeutic hypothermia. PLoS ONE. 14(2). e0211910–e0211910. 23 indexed citations

Southall, Noel, Madhusudan Natarajan, Lilian Pek Lian Lau, et al.. (2019). The use or generation of biomedical data and existing medicines to discover and establish new treatments for patients with rare diseases – recommendations of the IRDiRC Data Mining and Repurposing Task Force. Orphanet Journal of Rare Diseases. 14(1). 225–225. 19 indexed citations

Groenendaal, Floris, Marcel P. H. van den Broek, Carin M. A. Rademaker, et al.. (2019). Phenobarbital, Midazolam Pharmacokinetics, Effectiveness, and Drug-Drug Interaction in Asphyxiated Neonates Undergoing Therapeutic Hypothermia. Neonatology. 116(2). 154–162. 26 indexed citations

Peeters‐Scholte, Cacha, Anouk de Bakker, Toine C. G. Egberts, et al.. (2019). Pharmacokinetics and short-term safety of the selective NOS inhibitor 2-iminobiotin in asphyxiated neonates treated with therapeutic hypothermia. Pediatric Research. 87(4). 689–696. 13 indexed citations

Gaag, Linda C. van der, et al.. (2015). An intercausal cancellation model for Bayesian-network engineering. International Journal of Approximate Reasoning. 63. 32–47. 9 indexed citations

Riet‐Nales, Diana A. van, et al.. (2015). Methods of administering oral formulations and child acceptability. International Journal of Pharmaceutics. 491(1-2). 261–267. 46 indexed citations

10.

Alderliesten, Thomas, Volker Auwärter, Cora H. Nijboer, et al.. (2014). Neuroprotection by Argon Ventilation after Perinatal Asphyxia: A Safety Study in Newborn Piglets. PLoS ONE. 9(12). e113575–e113575. 24 indexed citations

11.

Riet‐Nales, Diana A. van, et al.. (2013). Acceptability of different oral formulations in infants and preschool children. Archives of Disease in Childhood. 98(9). 725–731. 100 indexed citations

12.

Kaandorp, Joepe J., Frank van Bel, Sylvia Veen, et al.. (2011). Long-term neuroprotective effects of allopurinol after moderate perinatal asphyxia: follow-up of two randomised controlled trials. Archives of Disease in Childhood Fetal & Neonatal. 97(3). F162–F166. 63 indexed citations

13.

Broek, Marcel P. H. van den, Floris Groenendaal, Toine C. G. Egberts, & Carin M. A. Rademaker. (2010). Effects of Hypothermia on Pharmacokinetics and Pharmacodynamics. Clinical Pharmacokinetics. 49(5). 277–294. 147 indexed citations

14.

Derks, Jan, Martijn A. Oudijk, Helen L. Torrance, et al.. (2010). Allopurinol Reduces Oxidative Stress in the Ovine Fetal Cardiovascular System Following Repeated Episodes of Ischemia-Reperfusion. Pediatric Research. 68(5). 1–1. 24 indexed citations

15.

Torrance, Helen L., Manon J.N.L. Benders, Jan Derks, et al.. (2009). Maternal Allopurinol During Fetal Hypoxia Lowers Cord Blood Levels of the Brain Injury Marker S-100B. Obstetrical & Gynecological Survey. 64(11). 705–706. 1 indexed citations

16.

Bartelink, Imke H., Robbert G. M. Bredius, Martine F. Raphaël, et al.. (2007). Once-Daily Intravenous Busulfan with Therapeutic Drug Monitoring Compared to Conventional Oral Busulfan Improves Survival and Engraftment in Children Undergoing Allogeneic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 14(1). 88–98. 58 indexed citations

17.

Toet, Mona C., et al.. (2005). Treatment of symptomatic congenital cytomegalovirus infection with valganciclovir. Journal of Perinatal Medicine. 33(4). 364–6. 46 indexed citations

18.

Rademaker, Carin M. A., et al.. (1993). Frequency of enterovirulentEscherichia coli in diarrhoeal disease in The Netherlands. European Journal of Clinical Microbiology & Infectious Diseases. 12(2). 93–97. 9 indexed citations

19.

Rademaker, Carin M. A., Wouter Jansen, Nanda Vos, et al.. (1991). Analysis ofEscherichia coli isolates from subjects with travellers' diarrhoea using DNA probes and serotyping. European Journal of Clinical Microbiology & Infectious Diseases. 10(8). 625–629. 6 indexed citations

20.

Rademaker, Carin M. A., et al.. (1989). Pharmacokinetics of a single dose of ofloxacin in healthy elderly subjects using noncompartmental and compartmental models. Pharmacy World & Science. 11(6). 224–228. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact